NEW YORK, March 3, 2026 /PRNewswire/ -- Elsevier today launches Osmosis AI, the first medical study companion to combine AI-powered conversation with the visual learning of Osmosis videos and 140 ...

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

In one seamless experience, students can access visual learning, verified and cited responses and personalized support, all based on trusted United States Medical Licensing Examination (USMLE) ...

Through Elsevier's ongoing partnership with Jisc, the agreement supports UK academic research institutions by combining reading access with open access publishing options, delivering the following ...

United by a commitment to advancing human progress, 5 pioneering scientists who are shaping the future of sustainable energy have been ...

A research report in the Journal of Nutrition Education and Behavior (JNEB), published by Elsevier, examined how the rapid digitalization of the retail food environment is reshaping food access in the ...

Computing is part of everything we do. Computing drives innovation in engineering, business, entertainment, education, and the sciences—and it provides solutions to complex, challenging problems of ...

Herzhoff, who was attending the India AI Impact Summit 2026 from February 16-20, reflected on a 2025 study in The Lancet Gastroenterology and Hepatology journal and said that de-skilling happens when ...

Elsevier, a global leader in advanced information and decision support in science and healthcare, today announces a three-year combined read and publish ...

Both polyphenols and probiotics are great for gut health for different reasons. Polyphenols feed existing bacteria, while probiotics introduce new bacteria into the gut.

The old industrial stalwarts of the FTSE 100, including BP, came back into investment fashion. BP is among what Goldman Sachs ...

There is a wide field of unofficial candidates. Whoever succeeds will take the helm of an agency in turmoil. John Zarocostas reports from Geneva.